EE9400040A - Oftalmiliseks otstarbeks mõeldud kompositsioon - Google Patents

Oftalmiliseks otstarbeks mõeldud kompositsioon

Info

Publication number
EE9400040A
EE9400040A EE9400040A EE9400040A EE9400040A EE 9400040 A EE9400040 A EE 9400040A EE 9400040 A EE9400040 A EE 9400040A EE 9400040 A EE9400040 A EE 9400040A EE 9400040 A EE9400040 A EE 9400040A
Authority
EE
Estonia
Prior art keywords
composition
ophthalmic use
ophthalmic
Prior art date
Application number
EE9400040A
Other languages
English (en)
Estonian (et)
Inventor
Urtti Arto
Järvinen Tomi
Suhonen Pekka
Lehmussaari Kari
Reunamäki Timo
Alaranta Sakari
Oksala Olli
Pohjala Esko
Hanhijärvi Hannu
Original Assignee
Leiras Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leiras Oy filed Critical Leiras Oy
Publication of EE9400040A publication Critical patent/EE9400040A/xx

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40Cyclodextrins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Medical Informatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EE9400040A 1993-06-24 1994-08-18 Oftalmiliseks otstarbeks mõeldud kompositsioon EE9400040A (et)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9302203A SE501482C2 (sv) 1993-06-24 1993-06-24 Komposition för topisk administration av bispilokarpinsyradiestrar till ögat i form av en vattenlösning

Publications (1)

Publication Number Publication Date
EE9400040A true EE9400040A (et) 1995-12-15

Family

ID=20390417

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9400040A EE9400040A (et) 1993-06-24 1994-08-18 Oftalmiliseks otstarbeks mõeldud kompositsioon

Country Status (5)

Country Link
AU (1) AU6973194A (sv)
EE (1) EE9400040A (sv)
LT (1) LT3525B (sv)
SE (1) SE501482C2 (sv)
WO (1) WO1995000144A1 (sv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2192965C (en) * 1994-07-11 2007-12-04 David W. Pate Anandamide analogue compositions and method of treating intraocular hypertension using same
GB9711643D0 (en) * 1997-06-05 1997-07-30 Janssen Pharmaceutica Nv Glass thermoplastic systems
US6933289B2 (en) 2003-07-01 2005-08-23 Allergan, Inc. Inhibition of irritating side effects associated with use of a topical ophthalmic medication
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
WO2023225113A1 (en) * 2022-05-18 2023-11-23 Bexson Biomedical, Inc. Complexing agent salt formulations of pharmaceutical compounds at low stoichiometric ratios

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58126810A (ja) * 1981-12-24 1983-07-28 Kaken Pharmaceut Co Ltd 抗炎症眼科用液剤およびその製法
TW200402B (sv) * 1990-08-13 1993-02-21 Senju Pharma Co
FI98815C (sv) * 1990-11-30 1997-08-25 Santen Oy Förfarande för framställning av nya farmakologiskt användbara esterderivat av bispilokarpinsyra

Also Published As

Publication number Publication date
LT3525B (en) 1995-11-27
LTIP1970A (en) 1995-01-31
SE9302203L (sv) 1994-12-25
SE501482C2 (sv) 1995-02-27
WO1995000144A1 (en) 1995-01-05
SE9302203D0 (sv) 1993-06-24
AU6973194A (en) 1995-01-17

Similar Documents

Publication Publication Date Title
BR9402379A (pt) Composição de borracha
FI961720A (sv) Ny komposition
IL115479A0 (en) Composition for ophthalmic use
FI941663A (sv) Komposition med en trikritisk punkt
DE69416947D1 (de) Kautschukzusammensetzung
DE59308042D1 (de) Ophthalmologisches Gerät
BR9407123A (pt) Composição herbicida
DK0614607T3 (da) Herbicid sammensætning
DE69430362D1 (de) Ektoparasitizide formulierung
EE9400040A (et) Oftalmiliseks otstarbeks mõeldud kompositsioon
EE9400039A (et) Oftalmiliseks otstarbeks mõeldud kompositsioon
KR950703340A (ko) 항엠알에스에이 조성물
ITMI920612A1 (it) Composizione oftalmica
ITMI911049A1 (it) Composizione oftalmica
BR9304388A (pt) Composição terapêutica de uso nasal
KR940021122U (ko) 안경다리
KR940027321U (ko) 안경
LTIP1969A (en) Composition for ophthalmic use
DK40893A (da) Mikrobicid sammensaetning
UA27833C2 (uk) Деревинно-клейова композиція
LT2338B (lt) 5-arginilaminonaftalin-1-sulfoamidu dihidrochloridai kaip pusiauproduktai 5-arginilaminonaftalin-1-sulfamidu gavimui
SE9302796D0 (sv) New use
SE9302709D0 (sv) New use
DK138293D0 (da) Oerevarmer
ITMI942406A0 (it) Distanziale -dosatoore per uso oftalmico